These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8948290)

  • 1. Agalactosyl IgG [Gal(o)]--an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis.
    Bodman-Smith K; Sumar N; Sinclair H; Roitt I; Isenberg D; Young A
    Br J Rheumatol; 1996 Nov; 35(11):1063-6. PubMed ID: 8948290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis.
    Lacki JK; Porawska W; Mackiewicz U; Mackiewicz S; Müller W
    Ann Med; 1996 Jun; 28(3):265-9. PubMed ID: 8811171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis.
    Chou CL; Wu MJ; Yu CL; Lu MC; Hsieh SC; Wu TH; Chou CT; Tsai CY
    Clin Rheumatol; 2010 Aug; 29(8):875-81. PubMed ID: 20229261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of 20-year outcome at onset of seropositive rheumatoid arthritis.
    Jäntti JK; Kaarela K; Luukkainen RK; Kautiainen HJ
    Clin Exp Rheumatol; 2000; 18(3):387-90. PubMed ID: 10895379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study.
    van Zeben D; Rook GA; Hazes JM; Zwinderman AH; Zhang Y; Ghelani S; Rademacher TW; Breedveld FC
    Br J Rheumatol; 1994 Jan; 33(1):36-43. PubMed ID: 8162455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS).
    Dixey J; Solymossy C; Young A;
    J Rheumatol Suppl; 2004 Mar; 69():48-54. PubMed ID: 15053454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agalactosyl IgG: an aid to differential diagnosis in early synovitis.
    Young A; Sumar N; Bodman K; Goyal S; Sinclair H; Roitt I; Isenberg D
    Arthritis Rheum; 1991 Nov; 34(11):1425-9. PubMed ID: 1953820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
    Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
    Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agalactosyl IgG is elevated in patients with active spondyloarthropathy.
    Leirisalo-Repo M; Hernandez-Munoz HE; Rook GA
    Rheumatol Int; 1999; 18(5-6):171-6. PubMed ID: 10399791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
    Yazici Y; Pincus T; Kautiainen H; Sokka T
    J Rheumatol; 2004 Sep; 31(9):1723-6. PubMed ID: 15338490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
    Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
    Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup.
    Drossaers-Bakker KW; Zwinderman AH; Vliet Vlieland TP; Van Zeben D; Vos K; Breedveld FC; Hazes JM
    Arthritis Rheum; 2002 Aug; 47(4):383-90. PubMed ID: 12209484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
    Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline.
    Alarcón GS; Willkens RF; Ward JR; Clegg DO; Morgan JG; Ma KN; Singer JZ; Steen VD; Paulus HE; Luggen ME; Polisson RP; Ziminski CM; Yarboro C; Williams HJ
    Arthritis Rheum; 1996 Mar; 39(3):403-14. PubMed ID: 8607889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.
    Lindqvist E; Saxne T; Geborek P; Eberhardt K
    Ann Rheum Dis; 2002 Dec; 61(12):1055-9. PubMed ID: 12429534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.